The drug nimodipine could prevent nerve cells from dying after brain surgery. Pharmacists at Martin Luther University Halle-Wittenberg (MLU), in cooperation with neurosurgeons at University Hospital Halle (Saale) (UKH), have developed a new method that enables the drug to be administered directly in the brain with fewer side effects. Their findings were published in the “European Journal of Pharmaceutics and Biopharmaceutics”.
- Do marketers matter for entrepreneurs?
- A new effect of red ginseng: suppression of lung cancer metastasis
- How are universities planning to tackle emissions associated with food and flying?
- Pressure-regulated excitonic feature enhances photocurrent of all-inorganic 2D perovski
- Sesaminol: Parkinson’s disease’s surprise medicine